Overview

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with painful diabetic polyneuropathy.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Analgesics